Guangdong Raynovent Biotech Co., Ltd
Clinical trials sponsored by Guangdong Raynovent Biotech Co., Ltd, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Radioactive tag reveals Drug's exit route in tiny trial Results expected Oct 2026 (estimated)
- New manufacturing site for RAY1225 put to the test Results expected Nov 2026 (estimated)
-
New manufacturing site for RAY1225 put to the test
Knowledge-focused Not yet recruitingResearchers are running a Phase 1 study to compare how the body handles RAY1225 injection made at a new site or batch versus the earlier version. Sixty-eight healthy volunteers receive a single 3 mg dose under the skin. The team measures drug levels in the blood over time and tra…
Phase 1 • Sponsor: Guangdong Raynovent Biotech Co., Ltd • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Radioactive tag reveals Drug's exit route in tiny trial
Knowledge-focused Not yet recruitingThis early-stage study gives 8 healthy men a single shot of a drug tagged with a radioactive tracer to see how it leaves the body through urine and stool. The goal is purely to understand the drug's breakdown and elimination, not to treat any disease. Participants must be healthy…
Phase 1 • Sponsor: Guangdong Raynovent Biotech Co., Ltd • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC